8-K
filed June 2, 2026, 8:48 AM ET
ticker INBS
CIK 0001725430
regulatory
confidence high
sentiment neutral
materiality 0.50
Intelligent Bio Solutions starts multi-site FDA 510(k) study for opiate codeine fingerprint test
INTELLIGENT BIO SOLUTIONS INC.
- Study will enroll 135 donor participants across multiple sites; partnered with CenExel Clinical Research.
- Designed to validate accuracy, sensitivity, specificity of the Intelligent Fingerprinting Drug Screening System for workplace use.
- Company expects to complete enrollment and data collection by end of July 2026.
- User performance evaluation by non-laboratory personnel is a key part of the 510(k) submission.
- Results will be confirmed via LC-MS/MS; study follows ICH GCP guidelines.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001493152-26-026780
- form_type
- 8-K
- ticker
- INBS
- cik
- 0001725430
- company_name
- INTELLIGENT BIO SOLUTIONS INC.
- filed_at
- 2026-06-02T12:48:18+00:00
- discovered_at
- 2026-06-02T12:50:00.265194+00:00
- generated_at
- 2026-06-02T12:50:11.103008+00:00
- sec_items
- ["7.01", "9.01"]
- event_type
- regulatory
- sentiment
- neutral
- materiality_score
- 0.5
- calibrated_materiality_score
- 0.5
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001493152-26-026780
- json_url
- https://secwatch.observer/filing/0001493152-26-026780.json
- markdown_url
- https://secwatch.observer/filing/0001493152-26-026780.md
- text_url
- https://secwatch.observer/filing/0001493152-26-026780.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1725430/000149315226026780/0001493152-26-026780-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1725430/000149315226026780/form8-k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
BDX
BD resumes ChloraPrep shipments after voluntary hold; all final release testing acceptable
BECTON DICKINSON & CO
May 29, 2026, 8:39 AM ET
regulatory
Items 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: regulatory
similar materiality
Filing page
SEC filing
TMC
NOAA certifies TMC USA's exploration license for USA B; 1.02B tonne nodule resource
TMC the metals Co Inc.
May 28, 2026, 9:04 AM ET
regulatory
Items 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: regulatory
similar materiality
Filing page
SEC filing
QBTS
D-Wave awarded year 2 funding for superconducting qubit fabrication project under U.S. DOW program
D-Wave Quantum Inc.
May 26, 2026, 7:01 AM ET
regulatory
Items 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: regulatory
similar materiality
Filing page
SEC filing
RICK
RCI Hospitality regains Nasdaq compliance after filing delayed Q1 10-Q
RCI HOSPITALITY HOLDINGS, INC.
June 1, 2026, 3:08 PM ET
regulatory
Items 8.01, 9.01
same SEC item: 9.01
same event type: regulatory
similar materiality
Filing page
SEC filing
FTHM
Fathom Holdings receives Nasdaq notice for late Q1 2026 10-Q filing; 60 days to submit plan
Fathom Holdings Inc.
May 29, 2026, 4:15 PM ET
regulatory
Items 3.01, 9.01
same SEC item: 9.01
same event type: regulatory
similar materiality
Filing page
SEC filing
LASE
Laser Photonics receives Nasdaq delisting notice for late Q1 2026 10-Q
Laser Photonics Corp
May 22, 2026, 5:27 PM ET
regulatory
Items 3.01, 9.01
same SEC item: 9.01
same event type: regulatory
similar materiality
Filing page
SEC filing
RICK
RCI receives Nasdaq noncompliance notice for late Q2 10-Q; deadline July 20
RCI HOSPITALITY HOLDINGS, INC.
May 22, 2026, 4:23 PM ET
regulatory
Items 3.01, 9.01
same SEC item: 9.01
same event type: regulatory
similar materiality
Filing page
SEC filing
AVXL
Anavex receives Nasdaq delinquency notice for late 10-Q filing; deadline July 20, 2026
ANAVEX LIFE SCIENCES CORP.
May 22, 2026, 8:15 AM ET
regulatory
Items 3.01, 8.01, 9.01
same SEC item: 9.01
same event type: regulatory
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.